Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marta Fabre
Observed names:
Fabre, Marta,
M FABRE,
M Fabre,
M. Fabre,
M., Fabre
Institutions:
Universidad de Zaragoza,
Instituto de Salud Carlos III,
Hospital Clínico Universitario Lozano Blesa,
Instituto de Investigación Sanitaria Aragón
Observed institutions:
Universidad de Zaragoza,
Instituto de Salud Carlos III,
University of Oxford,
Hospital Clínico Universitario Lozano Blesa,
Instituto de Investigación Sanitaria Aragón
ORCID:
0000-0003-4744-0903
Observed ORCID:
0000-0003-4744-0903
OpenAlex ID:
A5034996351
Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study
2023
·
Jose Villar
, Constanza P Soto Conti
, et al.
·
The Lancet
·
163
Maternal vaccination against COVID-19 and neonatal outcomes during Omicron: INTERCOVID-2022 study
2024
·
Fernando C. Barros
, Robert B. Gunier
, et al.
·
American Journal of Obstetrics and Gynecology
·
38
Angiogenic factors versus fetomaternal Doppler for fetal growth restriction at term: an open-label, randomized controlled trial
2025
·
Pablo Garcia-Manau
, Erika Bonacina
, et al.
·
Nature Medicine
·
21
Frequent Placental SARS-CoV-2 in Patients with COVID-19-Associated Hypertensive Disorders of Pregnancy
2021
·
M Fabre
, P Calvo
, et al.
·
Fetal Diagnosis and Therapy
·
19
PDF
Maternal plasma cell-free RNA as a predictor of early and late-onset preeclampsia throughout pregnancy
2025
·
Nerea Castillo-Marco
, Teresa Cordero
, et al.
·
Nature Communications
·
8
PDF
SARS-CoV-2 immunochromatographic IgM/IgG rapid test in pregnancy: A false friend?
2020
·
M Fabre
, S Ruiz-Martinez
, et al.
·
Annals of Clinical Biochemistry International Journal of Laboratory Medicine
·
8
PDF
Placental Infection Associated with SARS-CoV-2 Wildtype Variant and Variants of Concern
2023
·
Ana Medel-Martinez
, Cristina Paules
, et al.
·
Viruses
·
7
PDF
The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial
2022
·
Pablo Garcia-Manau
, Manel Mendoza
, et al.
·
JMIR Research Protocols
·
7
PDF
Pregnancy Outcomes and Vaccine Effectiveness During the Period of Omicron as the Variant of Concern, INTERCOVID-2022: A Multinational, Observational Study
2023
·
J. Villar
, C.P. Soto Conti
, et al.
·
Obstetric Anesthesia Digest
·
5
The placental transcriptomic profile determined by maternal COVID-19 disease encompasses alterations reminiscent of preeclampsia
2025
·
Ana Medel-Martinez
, Mark Strunk
, et al.
·
Placenta
·
4
PDF
First-Trimester Sequential Screening for Preeclampsia Using Angiogenic Factors: Study Protocol for a Prospective, Multicenter, Real Clinical Setting Study
2022
·
Cristina Trilla
, Cristina Luna
, et al.
·
Frontiers in Cardiovascular Medicine
·
4
PDF
SARS‐CoV‐2 congenital infection and pre‐eclampsia‐like syndrome in dichorionic twins: A case report and review of the literature
2021
·
Natalia Abadía‐Cuchí
, Sara Ruiz‐Martínez
, et al.
·
International Journal of Gynecology & Obstetrics
·
4
PDF
The impact of demand management on vitamin D testing
2025
·
Diego Aparicio-Pelaz
, Juan José Puente-Lanzarote
, et al.
·
Biochemia Medica
·
3
PDF
Direct and indirect reference intervals of 25-hydroxyvitamin D
2024
·
Marta Fabre
, Juan José Puente-Lanzarote
, et al.
·
Biochemia Medica
·
3
PDF
COVID-19 vaccination status during pregnancy and preeclampsia risk: the pandemic-era cohort of the INTERCOVID consortium
2026
·
Paolo Ivo Cavoretto
, Jose Villar
, et al.
·
EClinicalMedicine
·
2
SARS-CoV-2 Infection Exacerbates Hypertensive Disorders in Pregnancy Through Vascular and Immune Pathways
2026
·
Marta Fabre
, Ana Medel-Martinez
, et al.
·
International Journal of Molecular Sciences
·
1
PDF
Impact of suspected preterm labour in foetal cardiovascular and metabolic programming: a prospective cohort study protocol
2024
·
Natalia Abadía-Cuchí
, Marcos Clavero-Adell
, et al.
·
BMJ Open
·
1
PDF
Evaluation of urinary biomarkers in relation to the serum sFlt-1/PlGF ratio in pregnant women with suspected placental dysfunction
2026
·
Eva Martinez-Marzo
, Maria Peran
, et al.
·
Clinica Chimica Acta
Alterations of placental HERV expression as a result of gestational COVID-19 disease
2026
·
Ana Medel-Martinez
, Mattia Bugatti
, et al.
·
Frontiers in Microbiology
Capítulo 3. Base de datos Prematuridad
2026
·
Pueyo, Victoria
, Rubio Aranda, Encarnación
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Capítulo 2. Base de datos Prematuridad
2026
·
Pueyo, Victoria
, Rubio Aranda, Encarnación
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Urinary placental growth factor stability as a critical factor in the reliability of preeclampsia diagnosis
2026
·
Marta Fabre
, Ana Medel-Martinez
, et al.
·
Biochemia Medica
PDF
Profiling of the 2022 placental transcriptome after maternal COVID-19 disease
2024
·
Ana Medel-Martínez
, Mark Strunk
, et al.
·
Placenta
Comparison of placental gene expression in COVID-19 and PE patients: markers representative of inflammation and endothelial damage
2023
·
Ana Medel-Martínez
, Mark Strunk
, et al.
·
Placenta
Management of fetal Growth Restriction at term by Angiogenic Factors versus feto-maternal Doppler (GRAFD) to avoid adverse perinatal outcomes: multicenter open-label randomized controlled trial study protocol (Preprint)
2022
·
Pablo Garcia-Manau
, Manel Mendoza
, et al.
Show more works
View as search
Works count:
29
Citation count:
298
H-index:
7
I10-index:
4
Year
Topic
Type